David Crasto, DO
Dermatology · Dania, FLNPI 1043771306
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $11,815 of the $14,455 with a category attached, or 81.7%. It is spread thinly across 30 manufacturers, the largest accounting for just 24.0% — the pattern of someone who eats at a lot of different presentations.
Across 387 payments — averaging $37.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Regeneron Healthcare Solutions, Inc.$3K
- Sanofi$951
- Johnson & Johnson$832
- Amgen$734
- Janssen Scientific Affairs, LLC$731
- plus $5K from 24 others
What the payments were for
- Consulting fees$2,12915%
- Speaking & faculty fees$971%
- Food & beverage$11,81582%
- Education$4143%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 109 | $3,468 |
| Regeneron Healthcare Solutions, Inc. | 31 | $3,136 |
| Sanofi | 26 | $951 |
| Johnson & Johnson | 44 | $832 |
| Amgen | 15 | $734 |
| Janssen Scientific Affairs, LLC | 6 | $731 |
| Galderma Laboratories, L.p. | 20 | $644 |
| Lilly USA, LLC | 21 | $491 |
| Incyte Corporation | 9 | $459 |
| LEO Pharma Inc. | 7 | $417 |
| Sun Pharmaceutical Industries Inc. | 12 | $336 |
| Organon | 10 | $322 |
| UCB, Inc. | 18 | $314 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 10 | $302 |
| Arcutis Biotherapeutics, Inc. | 5 | $222 |
| Genentech USA, Inc. | 7 | $210 |
| Novartis | 10 | $192 |
| Sanofi-aventis U.S. LLC | 2 | $145 |
| EPI Health, LLC | 1 | $97 |
| Mayne Pharma Commercial LLC | 6 | $94 |
| Journey Medical Corporation | 5 | $83 |
| Dermavant Sciences, Inc. | 2 | $47 |
| VYNE Pharmaceuticals Inc. | 2 | $42 |
| Almirall LLC | 2 | $41 |
| Botanix SB Inc | 2 | $34 |
| Kyowa Kirin, Inc. | 1 | $28 |
| Boehringer Ingelheim | 1 | $26 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $21 |
| Paratek Pharmaceuticals, Inc. | 1 | $19 |
| Coherus Oncology, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$14,455 in reported general payments places this provider in the 85th percentile of 1,147 dermatology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other dermatology in Dania
- Francisco KerdelMiami$2.1M
- Brad GlickMargate$2M
- Robert KirsnerMiami$1.4M
- John MinniStuart$1.4M
- Gil YosipovitchMiami$1M
- Shino Bay AguileraFt Lauderdale$1M
- Robert SnyderPembroke Pines$1M
- Marc IngleseTallahassee$989K
- Jeremy GreenCoral Gables$952K
- Mercedes GonzalezMiami$943K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.